A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD

Completed · Phase 3

Conditions studied: COPD

In brief

The purpose of this study is to evaluate the safety and efficacy of the concomitant treatment of formoterol fumarate with tiotropium bromide compared to treatment with tiotropium bromide alone.

Key facts

Study ID

NCT00308191

Run by

Dey

People needed

128

Starts

2006-04-01

Expected to finish

2006-12-01

Last updated by the study team

2008-03-07

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Medical diagnosis of COPD
• Current or prior history of cigarette smoking

You may not qualify if…

• Medical diagnosis of asthma
• Significant condition or disease other than COPD

Where it is running

• Research Site — Phoenix, Arizona, United States
• Research Site — Los Angeles, California, United States
• Research Site — Sepulveda, California, United States
• Research Site — Walnut Creek, California, United States
• Research Site — Colorado Springs, Colorado, United States
• Research Site — Tamarac, Florida, United States
• Research Site — Gainesville, Georgia, United States
• Research Site — Auburn, Maine, United States
• Research Site — Ann Arbor, Michigan, United States
• Research Site — Livonia, Michigan, United States
• Research Site — St Louis, Missouri, United States
• Research Site — Liverpool, New York, United States
• Research Site — Rochester, New York, United States
• Research Site — Medford, Oregon, United States
• Research Site — Collegeville, Pennsylvania, United States
• Research Site — El Paso, Texas, United States
• Research Site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.